| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000042441 |
| Receipt No. | R000048427 |
| Scientific Title | Epidemic research to assess health disparities |
| Date of disclosure of the study information | 2020/11/16 |
| Last modified on | 2020/11/13 (Ver. 1) |
| Basic information | ||
| Public title | Research to assess health disparities | |
| Acronym | Research about health disparities | |
| Scientific Title | Epidemic research to assess health disparities | |
| Scientific Title:Acronym | Epidemic research about health disparities | |
| Region |
|
|
| Condition | ||||||
| Condition | Healthy controls, allergic diseases, et cetera. | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | To assess health disparities |
| Basic objectives2 | Others |
| Basic objectives -Others | To assess health disparities in infancy and childhood |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Health disparities |
| Key secondary outcomes | The relationship between clinical factors and diseases including allergic diseases in infancy and childhood.
The relationship between allergic rhinitis, asthma, and atopic dermatitis. The relationship between first milk and allergic diseases, etc. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Children born in 2001 and 2010 | |||
| Key exclusion criteria | Those who do not consent with this study.
|
|||
| Target sample size | 80000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka International Cancer Institute | ||||||
| Division name | Cancer Control Center | ||||||
| Zip code | 541-8567 | ||||||
| Address | 1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan | ||||||
| TEL | +81-6-6945-1181 | ||||||
| tabuchitak@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Osaka International Cancer Institute | ||||||
| Division name | Cancer Control Center | ||||||
| Zip code | 541-8567 | ||||||
| Address | 1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan | ||||||
| TEL | +81-6-6945-1181 | ||||||
| Homepage URL | |||||||
| tabuchitak@gmail.com | |||||||
| Sponsor | |
| Institute | Osaka International Cancer Institute |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of education, culture, sports, science and technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka International Cancer Institute |
| Address | 1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan |
| Tel | +81-6-6945-1181 |
| rinri01@opho.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 1508119060 |
| Org. issuing International ID_1 | Osaka International Cancer Institute |
| Study ID_2 | 1508119060-2 |
| Org. issuing International ID_2 | Osaka International Cancer Institute |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 85564 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048427 |